Emily M. Leproust - Mar 6, 2024 Form 4 Insider Report for Twist Bioscience Corp (TWST)

Signature
/s/ Alyssa Zhang, as Attorney-in-Fact for Emily M. Leproust
Stock symbol
TWST
Transactions as of
Mar 6, 2024
Transactions value $
-$55,658
Form type
4
Date filed
3/8/2024, 04:05 PM
Previous filing
Feb 6, 2024
Next filing
Mar 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TWST Common Stock Sale -$55.7K -1.49K -0.29% $37.43 516K Mar 6, 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TWST Employee Stock Option (right to buy) 24.4K Mar 6, 2024 Common Stock 0 $5.95 Direct F3
holding TWST Employee Stock Option (right to buy) 151K Mar 6, 2024 Common Stock 0 $8.82 Direct F4
holding TWST Employee Stock Option (right to buy) 267K Mar 6, 2024 Common Stock 0 $26.66 Direct F5
holding TWST Employee Stock Option (right to buy) 131K Mar 6, 2024 Common Stock 0 $23.33 Direct F6
holding TWST Employee Stock Option (right to buy) 65K Mar 6, 2024 Common Stock 65K $67.85 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
F2 Includes shares that were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
F3 The option is immediately exercisable. 25% of the shares subject to the option vested on September 1, 2016 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F4 The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F5 20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F6 25% of the shares subject to the option vested on October 24, 2020, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F7 Represents performance stock options granted to the reporting person on September 1, 2020, that vested and became exercisable on December 19, 2022 as a result of the reporting person having met the applicable performance criteria.